Humana (HUM)
(Delayed Data from NYSE)
$328.33 USD
+3.50 (1.08%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $328.14 -0.19 (-0.06%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Income Statements
Fiscal Year end for Humana Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 106,374 | 92,870 | 83,064 | 77,155 | 64,888 |
Cost Of Goods | 88,394 | 75,690 | 69,199 | 61,628 | 53,857 |
Gross Profit | 17,980 | 17,180 | 13,865 | 15,527 | 11,031 |
Selling & Adminstrative & Depr. & Amort Expenses | 13,967 | 13,380 | 10,717 | 10,541 | 7,839 |
Income After Depreciation & Amortization | 4,013 | 3,800 | 3,148 | 4,986 | 3,192 |
Non-Operating Income | -137 | 169 | 532 | -103 | 506 |
Interest Expense | 493 | 401 | 326 | 283 | 242 |
Pretax Income | 3,383 | 3,568 | 3,354 | 4,600 | 3,456 |
Income Taxes | 836 | 762 | 485 | 1,307 | 763 |
Minority Interest | -5 | -4 | 1 | 0 | 0 |
Investment Gains/Losses | -63 | -4 | 65 | 74 | 14 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 2,484 | 2,802 | 2,934 | 3,367 | 2,707 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 2,489 | 2,806 | 2,933 | 3,367 | 2,707 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 4,985 | 4,645 | 3,861 | 5,602 | 3,767 |
Depreciation & Amortization (Cash Flow) | 972 | 845 | 713 | 616 | 575 |
Income After Depreciation & Amortization | 4,013 | 3,800 | 3,148 | 4,986 | 3,192 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 124.44 | 127.09 | 129.40 | 133.01 | 134.73 |
Diluted EPS Before Non-Recurring Items | 26.09 | 25.24 | 20.64 | 18.75 | 17.87 |
Diluted Net EPS (GAAP) | 20.00 | 22.08 | 22.67 | 25.31 | 20.10 |
Fiscal Year end for Humana Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 26,462.00 | 26,423.00 | 26,747.00 | 26,742.00 |
Cost Of Goods | NA | 22,782.00 | 21,745.00 | 22,009.00 | 21,858.00 |
Gross Profit | NA | 3,680.00 | 4,678.00 | 4,738.00 | 4,884.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4,028.00 | 3,472.00 | 3,302.00 | 3,165.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -348.00 | 1,206.00 | 1,436.00 | 1,719.00 |
Non-Operating Income | NA | -97.00 | 6.00 | -54.00 | 8.00 |
Interest Expense | NA | 146.00 | 114.00 | 120.00 | 113.00 |
Pretax Income | NA | -591.00 | 1,098.00 | 1,262.00 | 1,614.00 |
Income Taxes | NA | -75.00 | 256.00 | 296.00 | 359.00 |
Minority Interest | NA | 1.00 | -2.00 | -3.00 | -1.00 |
Investment Gains/Losses | NA | -24.00 | -12.00 | -10.00 | -17.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -540.00 | 830.00 | 956.00 | 1,238.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -541.00 | 832.00 | 959.00 | 1,239.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 122.46 | 123.98 | 125.11 | 125.56 |
Diluted EPS Before Non-Recurring Items | NA | -0.11 | 7.78 | 8.94 | 9.38 |
Diluted Net EPS (GAAP) | NA | -4.24 | 6.71 | 7.66 | 9.87 |